Lime Nectarine
A citrus-forward hybrid marketed by Compound Genetics, with limited public data and no clinical research on its effects.
Lime Nectarine is a boutique cross from Compound Genetics that gets talked up for a bright citrus nose. Beyond that, almost everything you'll read about it — precise THC numbers, effect predictions, terpene percentages — comes from breeder marketing or single lab certificates, not replicated data. Treat the flavor descriptions as plausible, the effect claims as anecdote, and the lineage as breeder-reported rather than verified. If you like citrus-dominant hybrids, it's worth trying; just don't expect the hype to be measurable.
Overview
Lime Nectarine is a hybrid cannabis cultivar attributed to Compound Genetics, a California-based breeding operation known for citrus- and gas-forward crosses built around their Grape Pie and Jet Fuel Gelato lines [1]. It circulates primarily as a limited seed release and boutique dispensary flower rather than a mass-market strain.
Public information about Lime Nectarine is thin. There are no peer-reviewed studies of this cultivar, no independent multi-lab chemotype surveys, and no long-run cultivation data outside of grower forums and breeder marketing. Almost every specific number you'll see attached to it — THC percentage, yield, flowering time — traces back to a single certificate of analysis or a breeder listing Weak / limited.
Chemistry: cannabinoids and terpenes
Dispensary certificates of analysis for flower sold as Lime Nectarine typically report total THC in the low- to mid-20% range, with CBD under 1%. This is consistent with most modern high-THC hybrids on the US market [2]. There is no published chemotype study specific to this cultivar No data.
The terpene profile is marketed as citrus-forward, and available COAs tend to show limonene as the dominant or co-dominant terpene, often alongside caryophyllene and smaller amounts of myrcene or linalool Weak / limited. Limonene-dominant chemotypes are relatively common across 'lime,' 'lemon,' and 'orange' named cultivars [3].
A note on folklore: you'll sometimes see claims that a specific terpene percentage (e.g. "myrcene above 0.5% makes a strain indica") predicts effects. That threshold has no basis in the peer-reviewed literature and is best treated as marketing folklore Disputed [3][4].
Reported effects
There are no clinical trials of Lime Nectarine, and no cultivar-specific pharmacology data. Everything below is user-reported anecdote from dispensary reviews and grower communities Anecdote.
Common subjective descriptions include a relaxed body feel with an alert head, and a short-lived euphoric onset — patterns reported for many high-THC, limonene-forward hybrids. The popular indica/sativa/hybrid classification is a poor predictor of actual effects; chemotype (cannabinoid + terpene content) and dose matter far more, and even those relationships are not well characterized at the individual-cultivar level [4][5] Disputed.
As with any ~20%+ THC flower, expect the usual acute risks: anxiety or panic at higher doses, dry mouth, increased heart rate, and impaired driving performance for several hours [6].
Lineage
Compound Genetics lists Lime Nectarine as a cross involving their Jet Fuel Gelato line with a citrus-leaning partner [1]. Exact parentage has been described inconsistently across seed listings and third-party databases, and some retail descriptions conflate it with other 'Lime' or 'Nectarine' named crosses from unrelated breeders Disputed.
This is the norm, not the exception. Cannabis strain lineages are almost never independently verified by genetic testing; most published pedigrees are breeder claims. Independent genotyping projects have repeatedly shown that samples sold under the same strain name can be genetically distinct, and samples sold under different names can be near-identical [7]. Treat any lineage chart for Lime Nectarine as breeder-reported, not established fact.
Cultivation basics
There is no published cultivation guide from a horticultural or academic source for Lime Nectarine specifically. Grower-reported notes suggest:
- Flowering time: roughly 56-63 days indoors Anecdote
- Structure: medium-height, moderate stretch after flip, typical of Gelato-family hybrids
- Feeding: standard for high-yield photoperiod hybrids; no unusual sensitivities reported
- Environmental preferences: benefits from cooler late-flower temperatures to preserve terpene expression, which is a general principle for citrus-dominant chemotypes rather than a cultivar-specific finding [8]
Seed availability has been limited to periodic Compound Genetics drops; verified clone-only cuts circulate in a small number of California and Arizona markets. If you're buying seeds or clones labeled 'Lime Nectarine' from a third party, provenance is a real concern given how often strain names are reused.
Marketing vs. reality
What's plausible:
- A limonene-forward, citrus-dominant nose
- THC in the range typical of modern boutique hybrids
- A general 'hybrid' effect profile that varies by person and dose
What's marketing:
- Specific effect promises ('creative,' 'euphoric,' 'daytime') — these are not clinically validated for any cultivar [4] Disputed
- Precise THC numbers advertised on packaging — lab-shopping and inflated potency reporting are well-documented problems in US cannabis markets [9]
- The idea that lineage alone tells you how flower will feel — genetics interact heavily with growing environment, harvest timing, and curing [7]
If Lime Nectarine appeals to you, buy a small amount, note the actual COA, and judge for yourself. That's better information than any strain page — including this one — can give you.
Sources
- Practitioner Compound Genetics. Breeder catalog and strain listings. Accessed 2024.
- Peer-reviewed Smart R, Caulkins JP, Kilmer B, Davenport S, Midgette G. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction. 2017;112(12):2167-2177.
- Peer-reviewed Hazekamp A, Tejkalová K, Papadimitriou S. Cannabis: From cultivar to chemovar II—A metabolomics approach to Cannabis classification. Cannabis and Cannabinoid Research. 2016;1(1):202-215.
- Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa versus Cannabis indica debate: An interview with Ethan Russo, MD. Cannabis and Cannabinoid Research. 2016;1(1):44-46.
- Peer-reviewed Zamengo L, Bettin C, Badocco D, Di Marco V, Miolo G, Frison G. The role of time and storage conditions on the composition of hashish and marijuana samples: A four-year study. Forensic Science International. 2019;298:131-137.
- Government National Institute on Drug Abuse (NIDA). Cannabis (Marijuana) DrugFacts.
- Peer-reviewed Sawler J, Stout JM, Gardner KM, Hudson D, Vidmar J, Butler L, Page JE, Myles S. The genetic structure of marijuana and hemp. PLoS ONE. 2015;10(8):e0133292.
- Peer-reviewed Booth JK, Bohlmann J. Terpenes in Cannabis sativa – From plant genome to humans. Plant Science. 2019;284:67-72.
- Reported Schwab N. Weed is stronger than ever — but potency claims on the label may be a lie. Leafly, 2022.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.